202
Maze Therapeutics, Inc.
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25
Assets
(positive)
Change from FY24 to FY25
millions USD
FY24:
FY25:
350
(positive)
Change from FY24 to FY25
millions USD
FY24:
38.9
FY25:
47.4
Total assets
Change from FY24 to FY25
millions USD
FY24:
241
FY25:
397
Liabilities & Equity
(negative)
Change from FY24 to FY25
millions USD
FY24:
20.7
FY25:
22.6
(negative)
Change from FY24 to FY25
millions USD
FY24:
23.0
FY25:
19.6
(positive)
Change from FY24 to FY25
millions USD
FY24:
−311
FY25:
355
Total liabilities & equity
millions USD
FY24:
–
FY25:
397
All amounts in millions USD